| Patents for C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018) |
|---|
| 10/17/2000 | US6133251 First stage daily dosage portion is natural estrogen, second stage daily dosage portion is a combination of natural estrogen and natural or synthetic gestogen, third stage daily dosage portion is natural estrogen, fourth dosage is placebo |
| 10/11/2000 | EP1042353A1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 10/11/2000 | CN1057304C 17,20-epoxide derivatives of pregnance, their preparation, their use in preparation of cortisome derivatives and intermediates |
| 10/11/2000 | CN1057303C Preparation process for 16 beta-methyl steroid and new intermediates thereof |
| 09/28/2000 | WO2000056758A1 METHOD FOR PRODUCING 4,4-DIMETHYL-3β-HYDROXYPREGNA-8,14-DIENE-21-CARBOXYLIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD |
| 09/28/2000 | DE19914019C1 Verfahren zur Herstellung von 4,4-Dimethyl-3beta-hydroxypregna-8,14-dien-21-carbonsäureestern, deren Verwendung und Zwischenprodukte im Verfahren A process for the preparation of 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters, their use and intermediates in the process |
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/13/2000 | EP1033991A1 Mometasone furoate suspensions for nebulization |
| 09/12/2000 | US6117994 Intermediates for 16β-methyl steroids |
| 09/12/2000 | US6117860 Nasally administering steroid which binds to a specific neuroepithelial receptor for alleviating premenstrual tension and anxiety |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 08/31/2000 | DE19908762A1 Verwendung von Dienogest in hoher Dosierung Use of dienogest in high doses |
| 08/30/2000 | CN1055930C Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/24/2000 | WO2000048604A1 Utilization of dienogest in high doses |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 07/19/2000 | EP1020191A1 Medicaments for hypolipidemic and hypoglycemic conditions |
| 07/19/2000 | EP1019060A1 Androgen synthesis inhibitors |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0900234B1 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis |
| 06/29/2000 | DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases |
| 06/28/2000 | EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 06/15/2000 | WO2000034307A1 Sterol phosphates used as deodorant substances |
| 06/15/2000 | WO2000034306A1 17β-ACYL-17α-PROPYNYL-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |
| 06/08/2000 | WO2000032313A1 Milling process for the production of finely milled medicinal substances |
| 06/08/2000 | DE19855956A1 Sterolphosphate Sterolphosphate |
| 06/08/2000 | CA2352779A1 Milling process for the production of finely milled medicinal substances |
| 06/06/2000 | US6072068 Treating glucocorticoid-dependent diseases or symptoms |
| 05/24/2000 | CN1254343A Pregnane 3,20 diol mono- and di-sulphates |
| 05/23/2000 | US6066627 Steroids as neurochemical initiators of change in human blood levels of LH |
| 05/17/2000 | CN1052489C Process for preparation of 16 alpha-methyl steroids |
| 05/10/2000 | CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 05/02/2000 | US6057439 Epoxysteroids |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | WO2000021511A2 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/20/2000 | CA2346693A1 Pregnane glucuronides |
| 04/20/2000 | CA2311937A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/13/2000 | WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | DE19845403A1 Mit Gallensäuren verknüpfte Porpanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Porpanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | CA2346085A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/29/2000 | EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS |
| 03/22/2000 | CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 03/21/2000 | US6040468 Method of preparing 16α, 17α-dialkylated steroids |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/15/2000 | CN1247187A Process for preparing dieneketonol acetate |
| 02/23/2000 | EP0980384A1 Pregnane 3,2o diol mono- and di-sulphates |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 02/15/2000 | CA2082284C Process for the preparation of 20-oxo 17.alpha.,21-dihydroxylated derivatives of pregnane and new intermediate compounds |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/11/2000 | CA2065311C Solid matrix system for transdermal drug delivery |
| 01/05/2000 | EP0969012A2 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/05/2000 | EP0969011A2 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/05/2000 | EP0763054B1 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/04/2000 | US6011023 Angiostatic steroids |
| 12/22/1999 | EP0515386B1 Glycoalkaloids |
| 11/30/1999 | US5994334 Androgen synthesis inhibitors |
| 11/30/1999 | US5994333 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 11/25/1999 | DE19823677A1 Verfahren zur Herstellung von 4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol und Zwischenprodukte im Verfahren (I) A process for the preparation of 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol, and intermediates in the process (I) |
| 11/17/1999 | EP0636139B1 Isolation of steroids containing a 5,7-diene functionality from a sterol mixture |
| 11/10/1999 | EP0955049A2 6 Beta-Hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 ene - 3,20 - dione, as an inhibitor of smooth muscle proliferation |
| 11/02/1999 | US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome |
| 10/28/1999 | WO1999054032A1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 10/28/1999 | CA2328160A1 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors |
| 10/26/1999 | US5972922 Steroids which inhibit angiogenesis |
| 10/21/1999 | WO1999052930A1 METHOD FOR PRODUCING 4,4-DIMETHYL-5α-CHOLESTA-8,14,24-TRIENE-3β-OL AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD |
| 10/06/1999 | EP0947504A1 16-ene-vitamin d derivatives |
| 10/05/1999 | US5962443 19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/16/1999 | DE19817521C1 Preparation of 4,4-dimethyl-5-alpha-cholesta-8,14,24-trien-3-beta-ol useful as meiosis regulator for the promotion of fertility |
| 09/16/1999 | DE19817520C1 Preparation of 4,4-dimethyl-5-alpha-cholesta-8,14,24-trien-3-beta-ol useful as meiosis regulator for the promotion of fertility |
| 09/15/1999 | EP0941361A1 A method for the preparation of steroid compounds |
| 09/15/1999 | CN1228782A Process for preparation of 17-esters of 9 'alpha', 21-dihalo-pregnane-11 'beta', 17 'alpha' diol-20-ones |
| 09/01/1999 | EP0886645B1 New 19-nor-pregnene derivatives |
| 08/25/1999 | CN1226837A Steroids as neurochemical stimulators of VNO to alleviate symptoms of PMS and anxiety |
| 08/17/1999 | US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 08/17/1999 | US5939409 Processes for the production of anti-inflammatory steroids |
| 08/04/1999 | CN1225098A 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 07/28/1999 | EP0931047A1 Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof |
| 07/27/1999 | US5929262 Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/07/1999 | CN1222159A 6,7-oxygenated steroids and uses related thereto |
| 07/01/1999 | WO1999032506A1 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES |
| 06/30/1999 | CN1220996A Intermediate for preparation of 16 Beta-methyl steroid |
| 06/29/1999 | CA1340616C Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor |
| 06/23/1999 | EP0923599A1 Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones |
| 06/17/1999 | WO1998020151A9 A method for the preparation of steroid compounds |
| 06/09/1999 | EP0920442A1 Process for producing eltanolone |
| 06/01/1999 | US5908944 Copper compound catalyst |